Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers

The immunosuppressive activity of mesenchymal stromal cells (MSCs) in graft versus host disease (GvHD) is well-documented, but their therapeutic benefit is rather unpredictable. Prospective randomized clinical trials remain the only means to address MSC clinical efficacy. However, the imperfect unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Tik Shing, Bertolino, Giuliana Minani, Giacomini, Chiara, Bornhäuser, Martin, Dazzi, Francesco, Galleu, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330053/
https://www.ncbi.nlm.nih.gov/pubmed/32670295
http://dx.doi.org/10.3389/fimmu.2020.01338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330053/
https://www.ncbi.nlm.nih.gov/pubmed/32670295
http://dx.doi.org/10.3389/fimmu.2020.01338

Ejemplares similares